GH Guardant Health, Inc. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
08:30
Jul 19
Jul 19
Buy Guardant Health and Natera on biotech rotation.
Retail investors are rotating out of crowded tech positions into biotech and healthcare. Guardant Health (liquid biopsy, early cancer detection) and Natera (genetic testing, recurrence monitoring) are leading liquid-biopsy companies that rank high among retail purchases. This rotation into defensive biotech leaders gives them added demand and supports a positive outlook.
MED
12:24
May 13
May 13
Long GH as part of a diversified basket of stocks the author buys daily for retirement.
HIGH
12:00
Apr 21
Apr 21
Cancer screening companies are growing rapidly.
Companies like Exact Sciences and Guardant Health are advancing colorectal cancer screening with stool-based and blood tests, respectively, making screening more convenient and increasing adoption. Blood tests are inflecting and multi-cancer early detection tests are emerging, which could lead to earlier cancer detection and better outcomes.
HIGH
About GH Analyst Coverage
Buzzberg tracks GH (Guardant Health, Inc.) across 3 sources. 2 bullish vs 0 bearish calls from 3 analysts. Sentiment: predominantly bullish (67%). 3 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Choi Chang-gyu, Andy Constan, Alex Karnal.